J&J, Google surgical robotics joint venture earns Indian regulators' approval

The Competition Commission of India said in a Tweet that it has approved the formation of Johnson & Johnson's ($JNJ) joint venture with Google ($GOOG) for work on surgical robotics. Multinational companies usually worry about receiving approvals from European and U.S. regulators, as well as Japanese and Chinese ones, because the countries have large markets and well-developed regulations. But Indian institutions want to have a say as well. After all, both companies do a lot of business in India, too. Similarly, while India has long relied on European and American regulators to filter out unsafe devices and generally accepts CE-marked medical technologies, it is aiming to improve its regulation of devices and create a post-market surveillance system to monitor products used within its borders. More

Suggested Articles

The two companies also plan to identify new potential targets and therapeutic candidates for inflammatory bowel disease, or IBD.

This would allow centralized, lab-based diagnostic hardware to process blood samples at scale, screening patients for previous infections.

GlaxoSmithKline and AstraZeneca are considering forming a joint lab to help the U.K. expand its supplies for COVID-19 testing, according to Bloomberg.